Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Guarner-Argente C; Ikematsu H; Osera S; Fraile M; Ibañez B; Marra-López C; Jerusalén-Gargallo C; Alonso Aguirre PA; Martinez-Ares D; Soto S; Ramos Zabala F; Alvarez-Gonzalez MA; Rodriguez Sánchez J; Múgica F; Nogales Rincon O; Herreros de Tejada A; Redondo-Cerezo E; Martínez-Cara J; López-Rosés L; Rodriguez-Tellez M; Garcia-Bosch O; de la Peña J; Pellisé M; Rivero-Sanchez L; Saperas E; Pérez-Roldán F; Lopez Viedma B; González-Santiago JM; Álvarez Delgado A; Cobian C; Pardeiro R; Valdivielso Cortázar E; Colan-Hernandez J; Gordillo J; Kaneko K; Albéniz E.

Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country.

Gastroenterologia y Hepatologia. 2022; 45(6): 440-449 Nº de citas: 1 [doi:10.1016/j.gastrohep.2021.07.005]

Montalvá E; Rodríguez-Perálvarez M; Blasi A; Bonanad S; Gavín O; Hierro L; Lladó L; Llop E; Pozo-Laderas JC; Colmenero J.

Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation

TRANSPLANTATION. 2022; 106(6): 1123-1131 Nº de citas: 15 [doi:10.1097/TP.0000000000004014]

Sepulveda-Crespo, D; Yelamos, MB; Diez, C; Gomez, J; Hontanon, V; Torresano-Felipe, F; Berenguer, J; Gonzalez-Garcia, J; Ibanez-Samaniego, L; Llop, E; Olveira, A; Martinez, J; Resino, S; Martinez, I.

Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis

BIOMEDICINE & PHARMACOTHERAPY. 2022; 150: Nº de citas: 4 [doi:10.1016/j.biopha.2022.113024]

Lopez-Cauce, B; Urquia, A; Menchen, L; Homma, K; Bolas-Fernandez, F; Garcia-Rodriguez, JJ; Puerto, M.

Lentinula edodes extract increases goblet cell number and Muc2 expression in an intestinal inflammatory model of Trichinella spiralis infection

BIOMEDICINE & PHARMACOTHERAPY. 2022; 150: Nº de citas: 9 [doi:10.1016/j.biopha.2022.112937]

Garcia-Martinez, R; Diaz-Ruiz, R; Poncela, M.

Management of Hepatic Encephalopathy Associated with Advanced Liver Disease

CLINICAL DRUG INVESTIGATION. 2022; 42(SUPPL 1): 5-13 Nº de citas: 7 [doi:10.1007/s40261-022-01146-6]

Rodriguez-Peralvarez, M; Colmenero, J; Gonzalez, A; Gastaca, M; Curell, A; Caballero-Marcos, A; Sanchez-Martinez, A; Di Maira, T; Herrero, JI; Almohalla, C; Lorente, S; Cuadrado-Lavin, A; Pascual, S; Lopez-Garrido, MA; Gonzalez-Grande, R; Gomez-Orellana, A; Alejandre, R; Zamora-Olaya, J; Bernal-Bellido, C; Chronic Immunosuppression Canc Spa.

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

AMERICAN JOURNAL OF TRANSPLANTATION. 2022; 22(6): 1671-1682 Nº de citas: 64 [doi:10.1111/ajt.17021]

Caballero-Marcos, A; Citores, MJ; Alonso-Fernandez, R; Rodriguez-Peralvarez, M; Valerio, M; Morales, JG; Cuervas-Mons, V; Cachero, A; Loinaz-Segurola, C; Inarrairaegui, M; Castells, L; Pascual, S; Vinaixa-Aunes, C; Gonzalez-Grande, R; Otero, A; Tome, S; Tejedor-Tejada, J; Fernandez-Yunquera, A; Gonzalez-Dieguez, L; Nogueras-Lopez, F; Blanco-Fernandez, G; Diaz-Fontenla, F; Bustamante, FJ; Romero-Cristobal, M; Martin-Mateos, R; Arias-Milla, A; Calatayud, L; Marcacuzco-Quinto, AA; Fernandez-Alonso, V; Gomez-Gavara, C; Munoz, P; Banares, R; Pons, JA; Salcedo, M.

Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

LIVER TRANSPLANTATION. 2022; 28(6): 1039-1050 Nº de citas: 8 [doi:10.1002/lt.26389]

Llovet, LP; Gratacos-Gines, J; Tellez, L; Gomez-Outomuro, A; Navascues, CA; Riveiro-Barciela, M; Vinuesa, R; Gomez-Camarero, J; Garcia-Retortillo, M; Diaz-Fontenla, F; Salcedo, M; Garcia-Eliz, M; Horta, D; Guerrero, M; Rodriguez-Peralvarez, M; Fernandez-Rodriguez, C; Albillos, A; G-Abraldes, J; Pares, A; Londono, MC.

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis

Hepatology Communications. 2022; 6(6): 1392-1402 Nº de citas: 9 [doi:10.1002/hep4.1889]

Serrano, MT; Sabroso, S; Esteban, LM; Berenguer, M; Fondevila, C; Lorente, S; Cortes, L; Sanchez-Antolin, G; Nuno, J; de la Rosa, G; Salcedo, M; Registry.

Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort

TRANSPLANT INTERNATIONAL. 2022; 35: Nº de citas: 33 [doi:10.3389/ti.2022.10263]

Turnes, J; Rincon, D; Calleja, JL; Delgado, MB; Rosales, JM; Andrade, RJ; Manzano, ML; Salmeron, FJ; Calvo, M; Gomez, J; Molina, E; Frias, YN; Galvez-Fernandez, RM; Vallejo-Senra, N; Paris, S; Lamadrid, RSD; Olveira, A.

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naive non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

Gastroenterologia y Hepatologia. 2022; 45(5): 342-349 Nº de citas: 2 [doi:10.1016/j.gastrohep.2021.05.015]

Rodriguez-Agudo, R; Goikoetxea-Usandizaga, N; Serrano-Macia, M; Fernandez-Tussy, P; Fernandez-Ramos, D; Lachiondo-Ortega, S; Gonzalez-Recio, I; Gil-Pitarch, C; Mercado-Gomez, M; Moran, L; Bizkarguenaga, M; Lopitz-Otsoa, F; Petrov, P; Bravo, M; Van Liempd, SM; Falcon-Perez, JM; Zabala-Letona, A; Carracedo, A; Castell, JV; Jover, R; Martinez-Cruz, LA; Delgado, TC; Cubero, FJ; Lucena, MI; Andrade, RJ; Mabe, J; Simon, J; Martinez-Chantar, ML.

Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen

Antioxidants. 2022; 11(5): Nº de citas: 6 [doi:10.3390/antiox11050897]

Semmler, G; Meyer, EL; Kozbial, K; Schwabl, P; Hametner-Schreil, S; Zanetto, A; Bauer, D; Chromy, D; Simbrunner, B; Scheiner, B; Stattermayer, AF; Pinter, M; Schofl, R; Russo, FP; Greenfield, H; Schwarz, M; Schwarz, C; Gschwantler, M; Lopez, SA; Manzano, ML; Ahumada, A; Banares, R; Pons, M; Rodriguez-Tajes, S; Genesca, J; Lens, S; Trauner, M; Ferenci, P; Reiberger, T; Mandorfer, M.

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

JOURNAL OF HEPATOLOGY. 2022; 76(4): 812-821 Nº de citas: 100 [doi:10.1016/j.jhep.2021.11.025]

Feakins, R; Torres, J; Borralho-Nunes, P; Burisch, J; Goncalves, TC; De Ridder, L; Driessen, A; Lobaton, T; Menchen, L; Mookhoek, A; Noor, N; Svrcek, M; Villanacci, V; Zidar, N; Tripathi, M.

ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease

JOURNAL OF CROHNS & COLITIS. 2022; 16(3): 343-368 Nº de citas: 30 [doi:10.1093/ecco-jcc/jjab141]

Martin-Hernandez, D; Gutierrez, IL; Gonzalez-Prieto, M; MacDowell, KS; Robledo-Montana, J; Tendilla-Beltran, H; Calleja-Rodriguez, N; Bris, AG; Ulecia-Moron, C; Moreno, B; Caso, JR; Garcia-Bueno, B; Rodrigues-Mascarenhas, S; Marin-Jimenez, I; Leza, JC; Menchen, L.

Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress

Scientific Reports. 2022; 12(1): Nº de citas: 5 [doi:10.1038/s41598-022-08011-8]

Guijarro, LG; Cano-Martinez, D; Toledo-Lobo, MV; Ruiz-Llorente, L; Chaparro, M; Guerra, I; Iborra, M; Cabriada, JL; Bujanda, L; Taxonera, C; Garcia-Sanchez, V; Marin-Jimenez, I; Barreiro-de Acosta, M; Vera, I; Martin-Arranz, MD; Mesonero, F; Sempere, L; Gomollon, F; Hinojosa, J; Zoullas, S; Monserrat, J; Menor-Salvan, C; Alvarez-Mon, M; Gisbert, JP; Ortega, MA; Hernandez-Breijo, B; GETECCU.

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity

Biomedicines. 2022; 10(3): Nº de citas: 7 [doi:10.3390/biomedicines10030727]

Marín-Jiménez I; Acosta MB; Esteve M; Castro-Laria L; García-López S; Ceballos D; Echarri A; Martín-Arranz MD; Busquets D; Llaó J; Navarro-Llavat M; Huguet JM; Argüelles-Arias F; Vicente R; Boudet JM; Díaz G; Sánchez-Migallón AM; Casellas F; for RAPIDA trial investigators.

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Gastroenterologia y Hepatologia. 2022; 45(3): 165-176 Nº de citas: 4 [doi:10.1016/j.gastrohep.2021.04.010]

Virseda-Berdices, A; Brochado-Kith, O; Diez, C; Hontanon, V; Berenguer, J; Gonzalez-Garcia, J; Rojo, D; Fernandez-Rodriguez, A; Ibanez-Samaniego, L; Llop-Herrera, E; Olveira, A; Perez-Latorre, L; Barbas, C; Rava, M; Resino, S; Jimenez-Sousa, MA.

Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(3): 719-726 Nº de citas: 7 [doi:10.1093/jac/dkab444]

Ye, H; Chen, CB; Wu, HH; Zheng, K; Martin-Adrados, B; Caparros, E; Frances, R; Nelson, LJ; del Moral, MG; Asensio, I; Vaquero, J; Banares, R; Avila, MA; Andrade, RJ; Lucena, MI; Martinez-Chantar, ML; Reeves, HL; Masson, S; Blumberg, RS; Gracia-Sancho, J; Nevzorova, YA; Martinez-Naves, E; Cubero, FJ.

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

Cell Death & Disease. 2022; 13(2): Nº de citas: 26 [doi:10.1038/s41419-022-04580-8]